Oxaliplatin Sandoz Dosage & Drug Information

Information is sourced from publicly available references. The information is for educational purpose of healthcare professionals and we are not liable for any loss or damage.

Core Prescribing Info

Contents

Oxaliplatin

Indications/Uses

In combination w/ 5-fluorouracil & folinic acid for metastatic colorectal cancer & adjuvant treatment of stage III (Duke's C) colon cancer after complete resection of primary tumour.

Dosage/Direction for Use

IV Adult Adjuvant treatment 85 mg/m² infused over 2-6 hr in 250-500 mL of glucose 5% (50 mg/mL) soln repeated every 2 wk for 12 cycles (6 mth). Metastatic colorectal cancer 85 mg/m² infused over 2-6 hr in 250-500 mL of glucose 5% (50 mg/mL) soln repeated every 2 wk until disease progression or unacceptable toxicity.

Contraindications

Hypersensitivity. Myelosuppression prior to starting 1st course. Peripheral sensitive neuropathy w/ functional impairment prior to 1st course. Severe renal function (CrCl <30 mL/min). Lactation.

MIMS Class

Cytotoxic Chemotherapy

ATC Classification

L01XA03 - oxaliplatin ; Belongs to the class of platinum-containing antineoplastic agents. Used in the treatment of cancer.

Regulatory Classification

POM

Presentation/Packing

Form

Oxaliplatin Sandoz conc for soln for infusion 5 mg/mL

Packing/Price

1's

Oxaliplatin Sandoz

oxaliplatin

Manufacturer:

Fareva Unterach GmbH